Manufacturer record
M.R. Healthcare Pvt. Ltd: regulatory record
Last checked 3 November 2026. Source: CDSCO monthly NSQ alerts and state drug-testing laboratories
4 batches manufactured by M.R. Healthcare Pvt. Ltd (Uttarakhand) were declared Not of Standard Quality between February 2023 and July 2023. Records are batch-specific findings by government laboratories as published in CDSCO's monthly alerts; where a company has stated that a flagged batch was counterfeit, that statement is noted when reported.
Most recent flagged batch: MDG281 K, AMLODIPINE AND ATENOLOL TABLETS IP (ALAMO -AT) (exp Oct 2024). CDTL Hyderabad (CDSCO lab) found it not of standard quality: Assay of Amlodipine Besilate equivalent to Amlodipine Only. Listed in the July 2023 alert.
Records by type
4 records linked to M.R. Healthcare Pvt. Ltd in the datasets we hold. A zero means nothing is on record in those datasets, not that nothing ever happened. What the labels mean.
CDSCO drug alerts: Not of Standard Quality and spurious drugs
Scope. A company appearing here is not a finding that its products are unsafe. Regulatory actions can apply to one batch, one formulation, one period or one state. Always check the linked government document for the current position, and tell us if something is out of date. How we label records.
Flagged batches per year
All flagged batches
| Product | Batch | Reason declared NSQ | Tested by | Alert |
|---|---|---|---|---|
| AMLODIPINE AND ATENOLOL TABLETS IP (ALAMO -AT) | Batch MDG281 KMfg Nov 2022 · Exp Oct 2024 | Assay of Amlodipine Besilate equivalent to Amlodipine OnlyAssay | CDTL HyderabadCDSCO lab | Jul 2023 |
| AMLODIPINE AND ATENOLOL TABLETS IP (ALAMO-AT) | Batch MDG226DMfg Apr 2022 · Exp Mar 2024 | Dissolution and AssayAssay | CDTL HyderabadCDSCO lab | Apr 2023 |
| AMLODIPINE AND ATENOLOL TABLETS IP (ALAMO-AT) | Batch MRT1846Mfg Dec 2021 · Exp Nov 2023 | Dissolution and AssayAssay | CDTL HyderabadCDSCO lab | Apr 2023 |
| AMLODIPINE AND ATENOLOL TABLETS IP (ALAMO-AT) | Batch MRT1846Mfg Dec 2021 · Exp Nov 2023 | Dissolution and AssayAssay | CDTL HyderabadCDSCO lab | Feb 2023 |
Right of reply. Manufacturers may submit a response or a laboratory re-test result; it is published unedited alongside this record. Submit a response.